PH26696A - The use of substituted 3,4-dihydro-2H-benzopyrans as remedies for obstructive functional disorders of the lungs - Google Patents

The use of substituted 3,4-dihydro-2H-benzopyrans as remedies for obstructive functional disorders of the lungs Download PDF

Info

Publication number
PH26696A
PH26696A PH38951A PH38951A PH26696A PH 26696 A PH26696 A PH 26696A PH 38951 A PH38951 A PH 38951A PH 38951 A PH38951 A PH 38951A PH 26696 A PH26696 A PH 26696A
Authority
PH
Philippines
Prior art keywords
dihydro
alkyl
dimethyl
denotes
benzolblpyran
Prior art date
Application number
PH38951A
Other languages
English (en)
Inventor
Heinrich Christian Englert
Erik Kalus
Dieter Mania
Bernward Schokens
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of PH26696A publication Critical patent/PH26696A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pyrane Compounds (AREA)
PH38951A 1988-07-19 1989-07-17 The use of substituted 3,4-dihydro-2H-benzopyrans as remedies for obstructive functional disorders of the lungs PH26696A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3824446A DE3824446A1 (de) 1988-07-19 1988-07-19 Verwendung substituierter 3,4-dihydro-2h-benzopyrane als heilmittel gegen obstruktive funktionsstoerungen der lunge und/oder stoerungen der ableitenden harnwege

Publications (1)

Publication Number Publication Date
PH26696A true PH26696A (en) 1992-09-15

Family

ID=6359009

Family Applications (1)

Application Number Title Priority Date Filing Date
PH38951A PH26696A (en) 1988-07-19 1989-07-17 The use of substituted 3,4-dihydro-2H-benzopyrans as remedies for obstructive functional disorders of the lungs

Country Status (18)

Country Link
EP (2) EP0351720B1 (da)
JP (1) JPH0273015A (da)
KR (1) KR900001367A (da)
AT (1) ATE110270T1 (da)
AU (1) AU621388B2 (da)
CA (1) CA1336891C (da)
CZ (1) CZ417091A3 (da)
DE (2) DE3824446A1 (da)
DK (1) DK171782B1 (da)
ES (1) ES2061816T3 (da)
FI (1) FI893460A7 (da)
HU (1) HU210149B (da)
IE (1) IE63872B1 (da)
IL (1) IL91015A (da)
NZ (1) NZ229961A (da)
PH (1) PH26696A (da)
PT (1) PT91197B (da)
ZA (1) ZA895459B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW244350B (da) * 1991-12-14 1995-04-01 Hoechst Ag
TW316850B (da) * 1992-02-28 1997-10-01 Takeda Pharm Industry Co Ltd
HUT72741A (en) * 1992-12-19 1996-05-28 Alkaloida Vegyeszeti Gyar Method for producing benzopyrane derivatives and pharmaceutical compositions containing them
GB9316111D0 (en) * 1993-08-04 1993-09-22 Pfizer Ltd Benzopyrans
AU2273301A (en) 1999-12-23 2001-07-09 Robert E. Coifman Methods and formulations for the efficient delivery of water-insoluble drugs by nebulizer
KR100475147B1 (ko) * 2002-09-09 2005-03-10 정의상 알루미나 분진 중의 유해가스 제거를 위한 탈취제 조성물
ATE407724T1 (de) 2002-11-12 2008-09-15 Warner Lambert Co Methode zur stimulierung von haarwuchs auf der basis von benzopyranen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3364734D1 (en) * 1982-10-19 1986-08-28 Beecham Group Plc Novel chromans and chromenes
GB8419515D0 (en) * 1984-07-31 1984-09-05 Beecham Group Plc Treatment
GB8513369D0 (en) * 1985-05-28 1985-07-03 Beecham Group Plc Treatment
DE3703227A1 (de) * 1987-02-04 1988-08-18 Hoechst Ag Substituierte 3,4-dihydro-2h-benzopyrane, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen
ES2058148T3 (es) * 1987-02-04 1994-11-01 Hoechst Ag N-benzopiranil-lactamas sustituidas con alquilo, procedimiento para su preparacion, su empleo, asi como preparados farmaceuticos a base de estos compuestos.

Also Published As

Publication number Publication date
NZ229961A (en) 1991-11-26
EP0351720A2 (de) 1990-01-24
AU3818989A (en) 1990-01-25
EP0560399A1 (de) 1993-09-15
FI893460A0 (fi) 1989-07-17
ATE110270T1 (de) 1994-09-15
EP0351720A3 (de) 1992-01-02
JPH0273015A (ja) 1990-03-13
CZ417091A3 (en) 1993-02-17
IE63872B1 (en) 1995-06-14
KR900001367A (ko) 1990-02-27
IL91015A (en) 1994-11-28
FI893460A7 (fi) 1990-01-20
DK171782B1 (da) 1997-05-26
DE3824446A1 (de) 1990-01-25
AU621388B2 (en) 1992-03-12
EP0351720B1 (de) 1994-08-24
CA1336891C (en) 1995-09-05
ZA895459B (en) 1990-03-28
PT91197B (pt) 1995-07-18
DK355489D0 (da) 1989-07-18
ES2061816T3 (es) 1994-12-16
PT91197A (pt) 1990-02-08
DK355489A (da) 1990-01-20
HU210149B (en) 1995-02-28
DE58908228D1 (de) 1994-09-29
HUT55988A (en) 1991-07-29
IE892323L (en) 1990-01-19

Similar Documents

Publication Publication Date Title
US5071871A (en) Pharmaceutically useful benzo(β)pyranes and pyranopyridines
JP2793195B2 (ja) ベンゾチアゾール誘導体
US5096914A (en) Novel benzopyran derivatives, processes for their preparation and their use and preparations containing the compounds
PL141134B1 (en) Method of manufacture of novel benzopyranes
EP0534443B1 (en) 3,6-Disubstituted pyridazine derivatives
JPS61293984A (ja) 活性化合物、その製法及びそれを含む医薬組成物
JP3048511B2 (ja) 新規なｎ−ピリジルカルボキサミドと誘導体、その製造方法及びそれらを含む薬剤組成物
AU604525B2 (en) Substituted 3,4-dihydro-2h-benzopyrans, processes for their preparation, their use and pharmaceutical products based on these compounds
JPH06329540A (ja) 動脈硬化性血管内膜肥厚抑制薬
JPH11508283A (ja) ベンゾフリル誘導体類及びそれらの用途
HUT54673A (en) Process for producing benzopirane derivatives and pharmaceutical compositions containing them as active components
US5206252A (en) Thiadiazolyl-amino derivatives of benzopyrans and indanes
US5250547A (en) Benzopyran derivatives
DE69910799T2 (de) Als inhibitoren der aicarftnützliche verbindungen
CA1336891C (en) Use of substituted 3,4-dihydro-2h-benzopyrans as remedies for obstructive functional disorders of the lungs and/or disorders of the efferent urinary passages
AU604089B2 (en) Alkyl-substituted n-benzopyranyllactams, a process for their preparation, their use, and pharmaceutical preparations based on these compounds
US5364878A (en) Use of substituted 3,4-dihydro-2H-benzopyrans as remedies for obstructive functional disorders of the lungs
JPS62174062A (ja) １，５−ベンゾジアゼピン誘導体およびその製造法
JPH02101074A (ja) ６‐アロイル‐置換３，４‐ジヒドロ‐２ｈ‐ベンゾピランおよびその製造方法
US5194442A (en) 2,3,4,5-tetrahydro-1-benzoxepins, the use thereof and pharmaceutical products based on these compounds